Total Holdings
106
Portfolio diversification across 106 positions

Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
View ticker symbols, company names, asset types, and allocation percentages for each position
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 | ![]() | Eli Lilly and Company | Stock | 16.32% |
| 2 | ![]() | UnitedHealth Group Incorporated | Stock | 7.14% |
| 3 | ![]() | Abbott Laboratories | Stock | 4.94% |
| 4 | ![]() | Gilead Sciences, Inc. | Stock | 4.37% |
| 5 | ![]() | AbbVie Inc | Stock | 3.98% |
| 6 | ![]() | Thermo Fisher Scientific Inc. | Stock | 3.87% |
| 7 | ![]() | Intuitive Surgical, Inc | Stock | 3.79% |
| 8 | ![]() | Danaher Corporation | Stock | 3.29% |
| 9 | ![]() | Becton, Dickinson and Company | Stock | 3.11% |
| 10 | ![]() | Cytokinetics, Incorporated | Stock | 2.78% |
| 11 | ![]() | Elanco Animal Health Incorporated | Stock | 2.56% |
| 12 | ![]() | Medtronic plc | Stock | 2.19% |
| 13 | ![]() | Cencora, Inc. | Stock | 1.92% |
| 14 | ![]() | Erasca, Inc. | Stock | 1.83% |
| 15 | ![]() | Agilent Technologies, Inc | Stock | 1.67% |
| 16 | ![]() | Arcellx Inc | Stock | 1.67% |
| 17 | ![]() | CVS Health Corporation | Stock | 1.67% |
| 18 | ![]() | Stryker Corporation | Stock | 1.62% |
| 19 | ![]() | Ascendis Pharma AS | Stock | 1.62% |
| 20 | ![]() | Dyne Therapeutics, Inc. | Stock | 1.55% |
| 21 | ![]() | Humana Inc. | Stock | 1.48% |
| 22 | ![]() | Biogen Inc. | Stock | 1.40% |
| 23 | ![]() | McKesson Corporation | Stock | 1.28% |
| 24 | ![]() | Mettler-Toledo International Inc | Stock | 1.26% |
| 25 | ![]() | DexCom, Inc. | Stock | 1.21% |
| 26 | ![]() | Vaxcyte, Inc. | Stock | 1.20% |
| 27 | ![]() | Sanofi | Stock | 1.19% |
| 28 | ![]() | Immunome, Inc. | Stock | 1.18% |
| 29 | ![]() | West Pharmaceutical Services, Inc. | Stock | 1.13% |
| 30 | ![]() | Regeneron Pharmaceuticals, Inc. | Stock | 1.10% |
| 31 | ![]() | Edwards Lifesciences Corporation | Stock | 1.08% |
| 32 | ![]() | The Cooper Companies, Inc | Stock | 0.97% |
| 33 | ![]() | Immatics NV | Stock | 0.95% |
| 34 | ![]() | BioNTech SE | Stock | 0.78% |
| 35 | ![]() | Waters Corporation | Stock | 0.74% |
| 36 | ![]() | Immunocore Holdings plc | Stock | 0.74% |
| 37 | ![]() | Apogee Therapeutics, Inc. Common Stock | Stock | 0.72% |
| 38 | ![]() | AstraZeneca PLC | Stock | 0.60% |
| 39 | ![]() | Black Diamond Therapeutics, Inc | Stock | 0.59% |
| 40 | ![]() | Denali Therapeutics Inc | Stock | 0.59% |
| 41 | ![]() | Bruker Corporation | Stock | 0.53% |
| 42 | ![]() | Molina Healthcare, Inc | Stock | 0.51% |
| 43 | ![]() | Roivant Sciences Ltd | Stock | 0.50% |
| 44 | ![]() | Immunovant Inc | Stock | 0.48% |
| 45 | ![]() | BCAX | Stock | 0.45% |
| 46 | ![]() | Oscar Health Inc | Stock | 0.43% |
| 47 | ![]() | Cabaletta Bio Inc | Stock | 0.43% |
| 48 | ![]() | Xenon Pharmaceuticals Inc | Stock | 0.41% |
| 49 | ![]() | Masimo Corporation | Stock | 0.40% |
| 50 | ![]() | Ionis Pharmaceuticals, Inc | Stock | 0.39% |